Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors

Author(s):
Wortman, B.G.; Nout, R.A.; Bosse, T.; Creutzberg, C.L. (0000-0002-7008-4321)
Published
2019
Publication type
Article / Letter to editor
Endometrial cancerAdjuvant treatmentRadiotherapyChemotherapyMolecular risk factorsMolecular alterationsTargeted therapiesCheckpoint inhibitorsPARP inhibitors
Date issued
2019-09-30
Language
English
Is part of
Current Oncology Reports (2019), No. 9
hdl
1887/121023
doi
10.1007/s11912-019-0825-z